FutureBridge

Biomaterials are moving from “device support” to “clinical advantage.” Smarter implants. Bioactive scaffolds. Targeted delivery. Faster healing. Better patient outcomes. But for MedTech leaders, the real question is not just what is scientifically possible - it is what can scale, differentiate, and create value. Join Deepthi B. and Roopali Singh for our upcoming webinar: Next-Gen Biomaterials: From Scientific Breakthrough to Scalable Value Creation We will unpack where next-gen biomaterials are gaining traction across orthopedics, wound care, cardiovascular, ophthalmology, drug delivery, and regenerative medicine - and what this means for R&D, product strategy, innovation, and market positioning. Expect a sharp view on: ➡️ What is working today ➡️ What is emerging next ➡️ Who is capturing value ➡️ Where MedTech teams should be paying attention For senior leaders shaping the next generation of medical devices and healthcare innovation, this is worth a conversation. 🎯Register now to join the session. #Futurebridge #Biomaterials #MedTechInnovation #MedicalDevices #RegenerativeMedicine #SmartBiomaterials #AdvancedMaterials #TissueEngineering #HealthcareInnovation

Will the next breakthrough come from regenerative medicine, smarter implants, targeted drug delivery, or entirely new therapies that redefine patient care? As biomaterials become more intelligent and application-driven, the focus is shifting from scientific possibility to clinical adoption, commercial scalability, and measurable patient outcomes. In just a few hours, our panel of industry experts will explore where biomaterials are already creating value, the challenges that remain, and the innovations poised to shape the next decade of healthcare and MedTech. If you are involved in R&D, innovation, product strategy, or healthcare technology, this is a conversation you won't want to miss.   There's still time to register. Join us: https://lnkd.in/d5tjBdgk #Biomaterials #HealthcareInnovation #MedTech #MedicalDevices #RegenerativeMedicine

This is the thinking behind our Food, Agriculture and Nutrition June edition of Kottmeyer's Almanac on Upstream AG. This month's briefing unpacks six structural themes shaping global upstream agriculture, from shifting trade dynamics and Farm Bill progress to fertilizer economics, credit pressures, drought-driven market repricing, and biosecurity. It concludes with four strategic imperatives designed to help leadership teams plan with greater confidence. If these are the decisions you make, this is the briefing you should be reading every month. Read it at https://lnkd.in/dAgwgsUX #Agribusiness #UpstreamAgriculture #MarketIntelligence #BusinessStrategy #CommodityMarkets #FoodSystems #FarmEconomics

The next breakthrough in healthcare won't come from a single discovery but it will come from biomaterials engineered to interact, heal, adapt, and even evolve. Here's why industry leaders are paying attention: 🔹 The global biomaterials market has already surpassed $200 billion and is growing at 15%+ annually, transforming from a niche innovation into a large-scale growth market. 🔹 The industry is moving beyond inert materials to smart, responsive, and living biomaterials capable of sensing their environment, supporting tissue regeneration, and enabling personalized therapies. 🔹 Structural megatrends including aging populations, rising chronic diseases, healthcare investment, and accelerating R&D are creating long-term demand that extends far beyond traditional medical devices. But scaling this opportunity isn't just about science. It's about navigating manufacturing complexity, commercialization pathways, regulatory hurdles, and identifying where the next billion-dollar value pools are emerging. If you're working in medical devices, life sciences, healthcare innovation, biomaterials, tissue engineering, or strategic R&D, this session is built for you. Tomorrow, we'll discuss where the market is headed and where the biggest opportunities will be created. Register now - https://lnkd.in/d5tjBdgk #Biomaterials #MedTech #RegenerativeMedicine #BiomedicalEngineering #MedicalDevices #HealthcareInnovation

Our latest report https://lnkd.in/dGZmDk6y explores the scientific, manufacturing, regulatory, and commercialization challenges preventing next-generation biomaterials from reaching their full potential. From biodegradable polymers and smart biomaterials to regenerative medicine, discover the trends and strategic opportunities shaping the future of MedTech. Ready to take the conversation beyond the report? Join our exclusive webinar https://lnkd.in/d5tjBdgk as industry experts analyze the technologies, market shifts, and commercialization strategies that will define the next era of biomaterials innovation. Discover the insights. Discuss what comes next. #Biomaterials #MedTech #RegenerativeMedicine #BiomedicalEngineering #MedicalDevices #HealthcareInnovation

As robotic surgery matures, the conversation is shifting from innovation to scalable adoption. It was a privilege to bring together leaders from ZEISS Group, Hydrix, and Moon Surgical for a candid exchange on the opportunities and challenges shaping the next phase of surgical robotics. With valuable perspectives from Craig Hoppé, Johannes Haak, Peter R. Lewis AM, Tushar A. and @Shannon Moore and moderated by Manoj Jiandani, Rachit Singla, the discussion focused on the questions that matter most: - Can telesurgery move beyond pilots to mainstream care? - How do reimbursement and market access influence adoption, particularly in emerging markets? - What evidence is needed to accelerate broader clinical acceptance? - How can emerging robotics companies compete and scale in a market led by established players? - What does sustainability mean in the context of robotic surgery? Thank you to everyone for contributing to an insightful discussion. Advancing robotic surgery will require not only technological innovation but also collaboration across industry, healthcare systems, and policy. #RoboticSurgery #SurgicalRobotics #MedTech #HealthcareInnovation #MarketAccess #SRS2026 #SRS #FutureBridge

The future of healthcare won't be shaped by therapies alone; it will be enabled by smarter biomaterials. From self-healing implants and bioresorbable scaffolds to AI-driven biomaterial design and 3D bioprinting, the next generation of biomaterials is redefining how we repair, regenerate, and personalize patient care. But scientific breakthroughs are only the beginning. How do these innovations translate into scalable manufacturing, clinical adoption, regulatory success, and commercial value? Join us for Next-Gen Biomaterials: From Scientific Breakthrough to Scalable Value Creation, where industry leaders will discuss: • The latest advances in next-generation biomaterials • AI, regenerative medicine, and 3D bioprinting • Commercialization and scale-up challenges • Emerging investment and partnership opportunities • The future of MedTech, drug delivery, and personalized healthcare Be part of the conversation shaping the next era of healthcare innovation. Register now:  https://lnkd.in/d5tjBdgk #Biomaterials #RegenerativeMedicine #MedicalDevices #3DBioprinting #DrugDelivery #HealthcareInnovation #MedTech #FutureBridge

Billions have gone into digital manufacturing. Connected machines. Smart factories. Data platforms. Automation layers. But one critical part of shopfloor execution is still often left under-augmented - the operator. And that is where the next shift in manufacturing operational excellence may come from. Join us for our LinkedIn Live webinar: Beyond Automation: Mastering Human Augmentation on the Shopfloor From smart factory to smart operator - the missing link in Industry 4.0 We will explore how AI-powered, connected ecosystems can help operators make better decisions in real time, standardise performance across shifts and sites, reduce downtime, improve OEE, and unlock more value from existing digital investments. Key discussion areas: • Why automation alone cannot solve shopfloor variability • How human augmentation improves decision-making at the point of execution • Where AI, edge technologies and connected systems can create measurable operational impact • What manufacturers should consider before scaling augmentation across plants For manufacturing, operations, digital transformation and industrial leaders, this is a timely conversation on where operational excellence is heading next. Register for the live webinar now! #futurebridge #Manufacturing #Industry4.0 #SmartFactory #DigitalManufacturing #OperationalExcellence #HumanAugmentation #ShopfloorExcellence

Just a few hours to go! Automation has transformed factories but what about the people running them? Join our webinar to discover how AI-powered copilots are empowering frontline operators with real-time intelligence to improve productivity, quality, and OEE. Today | 23 July 2026 Register now:  https://lnkd.in/dzHTmF47 #Manufacturing #Industry40 #IndustrialAI #ConnectedWorker #FutureBridge

The most valuable part of Society of Robotic Surgery | SRS 2026 won't just be what's unveiled on stage, it's the conversations happening around it. Our team of Manoj Jiandani, Rachit Singla, and Raj Gill are at Hollywood, Florida, connecting with the surgeons, innovators, researchers, and industry leaders shaping the future of robotic surgery. Over the next few days, they will be exploring how surgical AI, digital operating rooms, and next-generation robotic platforms are moving from promise to practice and, more importantly, what these shifts mean for hospitals, medtech companies, and the future of care. They will be bringing back the insights that matter most - the ones that emerge from conversations, not just presentations. If you're attending SRS 2026, we'd love to connect. #SRS2026 #SRS #roboticsurgery #medtech #FutureBridge